HOME     CONTACT     BACK

 
 
 
THE PHARMA REVIEW APRIL - MAY 2007

The Patent Truth

Varun Soni

Abstract: Recently, Ranbaxy Laboratories, India’s largest pharmaceutical company, won a patent litigation case against Pfizer for a cholesterol lowering drug called Atorvastatin marketed by Pfizer as Lipitor. The Oslo City Court sided with Ranbaxy by finding the non-infringement of two of Pfizer’s Norwegian patents covering particular internmediate compounds. Many term this victory as a ‘matter of pride’ for Indians across the world. But, do you know what goes into preparing and applying for a patent of winning lawsuits for intellectual property? Or who the people behind the scenes are and how they get there? Well, probably not. Intellectual Property Rights (IPR) is still at a nascent stage in India, but if experts are to be believed, then the future will see job opportunities running into thousands. Says Vindo Khurana, Executive Director, Institute of Intellectual Property Research and Practices, “As of now, most pharma and software companies in India have an IPR cell. But, with awareness growing, this trend is going to find acceptance in other industries as well, increasing the demand for professionals in this sector.”

 
Go to Content Index Page

PHARMA REVIEW - ARTICLES ARCHIVE ( COMPLETE LIST)

The above content is an abstract only. For the full Article please contact:
KONGPOSH Publications Pvt. Ltd.
ICS House, C-19, Commercial Complex, SDA, Opp. IIT Gate, New Delhi, India -110016
Tel.: 26855839, 20057149, Fax: 91-11-26855876
Email: info@kppub.com / fpc@vsnl.com, Website: http://www.kppub.com

 
 
 

 Copyright 2008. KONGPOSH PUBLICATIONS Pvt. Ltd.